1,054 results on '"Lee, Wei-Jei"'
Search Results
102. Recruitment and Screening for a Randomized Trial Comparing Roux-en-Y Gastric Bypass to Intensive Medical Management for Treatment of Type 2 Diabetes
103. A Randomized Trial Comparing Roux-en-Y Gastric Bypass to Intensive Medical Management in Obese Patients with Type 2 Diabetes Mellitus
104. Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass
105. Recruitment and Screening for a Randomized Trial Investigating Roux-en-Y Gastric Bypass versus Intensive Medical Management for Treatment of Type 2 Diabetes
106. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy
107. Revisional surgery for laparoscopic minigastric bypass
108. Single-Anastomosis Gastric Bypass (SAGB): Appraisal of Clinical Evidence
109. Laparoscopic Nissen Fundoplication with Gastric Plication as a Potential Treatment of Morbidly Obese Patients with GERD, First Experience and Results
110. Laparoscopic Sleeve Gastrectomy Versus Single Anastomosis (Mini-) Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus: 5-Year Results of a Randomized Trial and Study of Incretin Effect
111. Efficacy of Metabolic Surgery on HbA1c Decrease in Type 2 Diabetes Mellitus Patients with BMI <35 kg/m2—a Review
112. Laparoscopic Single-Anastomosis Duodenal–Jejunal Bypass with Sleeve Gastrectomy (SADJB-SG): Short-term Result and Comparison with Gastric Bypass
113. Bariatric Surgery for Patients With Type 2 Diabetes—Reply
114. Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes
115. The relationship of visfatin/pre–B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids
116. Reply to the Letter “Gastric Remnant Dilatation: a Rare Technical Complication Following Laparoscopic One Anastomosis (Mini) Gastric Bypass”
117. Severe obesity is associated with novel single nucleotide polymorphisms of theESR1 and PPARγ locus in Han Chinese
118. Comment on: “Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.”
119. Randomized Controlled Trials in Bariatric Surgery
120. Laparoscopic Roux-en-Y Vs. Mini-gastric Bypass for the Treatment of Morbid Obesity: a 10-Year Experience
121. Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis
122. IFSO-APC Consensus Statements 2011
123. Bariatric Surgery in Asia in the Last 5 Years (2005–2009)
124. C-peptide Predicts the Remission of Type 2 Diabetes After Bariatric Surgery
125. Gastrointestinal Metabolic Surgery for the Treatment of Diabetic Patients: A Multi-Institutional International Study
126. ESR1, FTO, and UCP2 Genes Interact with Bariatric Surgery Affecting Weight Loss and Glycemic Control in Severely Obese Patients
127. Diabetes Remission and Insulin Secretion After Gastric Bypass in Patients with Body Mass Index <35 kg/m2
128. Expression of subcutaneous adipose tissue phosphoenolpyruvate carboxykinase correlates with body mass index in nondiabetic women
129. Experience in laparoscopic sleeve gastrectomy for morbidly obese Taiwanese: staple-line reinforcement is important for preventing leakage
130. Clinical Predictors of Obstructive Sleep Apnea in Asian Bariatric Patients
131. Effects of Obesity Surgery on Type 2 Diabetes Mellitus Asian Patients
132. Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients
133. Improvement of Insulin Resistance After Obesity Surgery: A Comparison of Gastric Banding and Bypass Procedures
134. Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Gallbladder Disease in Morbid Obesity
135. Effect of Laparoscopic Mini-Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI >35 and <35 kg/m2
136. Clinical Characteristics and Outcome of Morbidly Obese Bariatric Patients with Concurrent Hepatitis B Viral Infection
137. Laparoscopic antireflux surgery for the elderly: A surgical and quality-of-life study
138. Laparoscopic Mini-gastric Bypass: Experience with Tailored Bypass Limb According to Body Weight
139. Correlations of Laparoscopy with Histology and Laboratory Studies on Liver Diseases in Bariatric Patients
140. The Serial Changes of Ghrelin and Leptin Levels and Their Relations to Weight Loss After Laparoscopic Minigastric Bypass Surgery
141. Metabolic Syndrome Is Related to Nonalcoholic Steatohepatitis in Severely Obese Subjects
142. Prediction of successful weight reduction after bariatric surgery by data mining technologies
143. Ala55Val Polymorphism on UCP2 Gene Predicts Greater Weight Loss in Morbidly Obese Patients Undergoing Gastric Banding
144. Gallbladder Disease among Obese Patients in Taiwan
145. Diagnostic Value of Ultrasonographic Examination for Nonalcoholic Steatohepatitis in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery
146. Hepatic Histopathology of Morbid Obesity: Concurrence of Other Forms of Chronic Liver Disease
147. Spectrum of Endoscopic Findings and Therapy in Patients with Upper Gastrointestinal Symptoms after Laparoscopic Bariatric Surgery
148. Prevention of Trocar-Wound Hernia in Laparoscopic Bariatric Operations
149. The Influence of Helicobacter pylori Infection on the Development of Gastric Ulcer in Symptomatic Patients after Bariatric Surgery
150. Gastric Ghrelin Expression Associated with Helicobacter pylori Infection and Chronic Gastritis in Obese Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.